Trials / Completed
CompletedNCT02636413
Evaluation of LacTEST for the Diagnosis of Hypolactasia in Adults and Elderly Patients Presenting With Clinical Symptoms of Lactose Intolerance
Evaluation of the Impact of LacTEST on Diagnostic Thinking and on Patient Management, and of the Reproducibility (Test-Retest), for the Diagnosis of Hypolactasia in Adults and Elderly Patients Presenting With Clinical Symptoms of Lactose Intolerance
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 1 (actual)
- Sponsor
- VenterPharma · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate both the impact of LacTEST on diagnostic thinking and on patient management, and its reproducibility (Test-Retest), for the diagnosis of hypolactasia in adults and elderly patients presenting with clinical symptoms of lactose intolerance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | gaxilose | After gaxilose administration, urine collection, cuantification (firstly from 0 to 4 hours, and total urine from 0 to 5 hours), and xilose cuantification afterwards. |
| DIETARY_SUPPLEMENT | lactose | After lactose administration, expired hydrogen measurement at pre-specified intervals. |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2016-10-01
- Completion
- 2016-10-01
- First posted
- 2015-12-21
- Last updated
- 2016-12-28
Locations
6 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT02636413. Inclusion in this directory is not an endorsement.